Share on StockTwits

ArQule (NASDAQ:ARQL) will be issuing its Q214 quarterly earnings data on Tuesday, August 5th. Analysts expect the company to announce earnings of ($0.12) per share and revenue of $2.43 million for the quarter.

ArQule (NASDAQ:ARQL) opened at 1.32 on Monday. ArQule has a 52 week low of $1.26 and a 52 week high of $2.94. The stock’s 50-day moving average is $1.43 and its 200-day moving average is $1.79. The company’s market cap is $82.8 million.

On the ratings front, analysts at MLV & Co
cut their price target on shares of ArQule from $3.00 to $1.75 in a research note on Monday, May 12th. They now have a “hold” rating on the stock. Five equities research analysts have rated the stock with a hold rating, ArQule currently has a consensus rating of “Hold” and an average price target of $2.95.

ArQule, Inc is a clinical-stage biotechnology company engaged in the research and development of cancer therapeutics.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.